Join us as two experts in gastrointestinal oncology respond to questions from the oncology community on the role of biomarker-targeted therapies in personalizing treatment decisions in patients with CRC.
In Module 1, they explore biomarker-led patient identification, current treatment options and considerations for anti-EGFR rechallenge.
In Module 2, they discuss the role of biomarkers in treatment sequencing and associated practical challenges, alongside emerging treatments and indications of interest.
Watch now: touchoncologyime.org/harnessi...
Register today to stay informed about Module 2:
touchoncology.com/your-free-1...
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
5 июн 2024
